A RANDOMIZED, DOUBLE-BLIND, MULTICENTER CROSSOVER TRIAL TO EVALUATE IN-VIVO INHIBITION OF AROMATASE BY ARIMIDEX (ZD1033)(1 MG AND 10 MG PO OD) IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER
M. Dowsett et al., A RANDOMIZED, DOUBLE-BLIND, MULTICENTER CROSSOVER TRIAL TO EVALUATE IN-VIVO INHIBITION OF AROMATASE BY ARIMIDEX (ZD1033)(1 MG AND 10 MG PO OD) IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 356-356